[Predictifs factors of the algodystrophy evolution in a rheumatology department among 60 cases]

Tunis Med. 2005 Mar;83(3):163-7.
[Article in French]

Abstract

We analysed 60 cases of algodystrophy admitted in the rheumatology department of the university hospital of Monastir. We used a univariate analysis to search the factors associated with the disease evolution. Our patients were 40 males and 20 females. The mean age was 51.6 ans (16 - 81). The traumatisme was the dominant cause (46.7% of the cases). Calcitonines were used in 70% of the cases. Functional results at one year were satisfying and not satisfying in 62.5% and 37.5% of the cases, respectively. The primitive algodystrophy was associated with a satisfying result. Sequella were observed in 10.5% of the cases. The primitive algodystrophy was associated with a satisfying result. Algodystrophy remain a benign disease and the best treatment remains the preventive one mainly in traumatic and orthopaedic circumstances.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Analgesics / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Calcitonin / therapeutic use
  • Diphosphonates / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Radionuclide Imaging
  • Reflex Sympathetic Dystrophy* / diagnosis
  • Reflex Sympathetic Dystrophy* / diagnostic imaging
  • Reflex Sympathetic Dystrophy* / drug therapy
  • Reflex Sympathetic Dystrophy* / etiology
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Analgesics
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antidepressive Agents, Tricyclic
  • Diphosphonates
  • Calcitonin